Arpida (SIX: ARPN) is a biopharmaceutical company headquartered in Reinach, near Basel, Switzerland with operations in Switzerland and the USA. It focuses on novel drugs that seek to overcome the growing problem of microbial resistance. Arpida’s leading product candidate is intravenous iclaprim, an antibiotic that targets severe infections requiring hospital treatment, including those caused by methicillin-resistant Staphylococcus aureus (MRSA).
Company Details
- Employees
- 30
- Founded
- -
- Phone
- +41 61 417 96 60
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- arpida.com
- Competitors
- BioVersys AG, BEAM Alliance, Venn Group.
Arpida Questions
Arpida's helpline number is +41 61 417 96 60
Arpida's website is arpida.com
Arpida's LinkedIn profile is https://ch.linkedin.com/company/arpida
Arpida has
30 employees.
View email and phone details for 30
employees at Arpida.
Arpida's industry is
Pharmaceutical Manufacturing
Arpida's categories are Pharmaceutical Manufacturing
Arpida's founding year is 1997
